Governance

Governance

The board of SkinBioTherapeutics recognises the importance of corporate governance. 

We are committed to operating with integrity and professionalism across all our activities. We believe that good governance protects shareholders, supports sustainable growth, and reduces risk. 

SkinBioTherapeutics follows the recommendations of the Corporate Governance Code published by the Quoted Companies Alliance in 2023 (the QCA Code).

 For investor enquiries, contact our investor relations team at ir@skinbiotix.com